In this article, we discuss the 5 stocks that recently received price-target cuts from analysts. If you want to read our detailed analysis of these companies, go directly to Analysts Just Decreased Price Targets of These 10 Stocks.
5. CRISPR Therapeutics AG (NASDAQ:CRSP)
Number of Hedge Fund Holders: 37
Evercore ISI lowered its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) from $66 per share to $60 per share on Thursday, June 23, 2022. The research firm is excited about the gene-editing programs of CRISPR Therapeutics AG (NASDAQ:CRSP), but thinks they are still in the initial stages.
Evercore ISI analyst Liisa Bayko believes that investors can’t get a clear picture of the efficacy of the company’s Type 1 diabetes (T1D) program by the end of 2023. Bayko also downgraded CRISPR Therapeutics AG (NASDAQ:CRSP) from “Outperform” to “In Line.”